Advertising imagery, too, falls under OPDP’s jurisdiction, Sunovion learned this week. Regulators took aim at one of the drugmaker’s professional print ads for seizure med Aptiom (eslicarbazepine ...

US FDA OPDP issued first untitled letter of 2023 to Xeris Pharmaceuticals concerning promotional material for Recorlev tablets, citing misleading claims on company w ...

Last month, I wrote a letter to The Herald regarding former Chancellor Thomas Tisch’s ’76 P’18 P’20 defense of the University’s acceptance of the blue bear statue from Steven Cohen, the infamous ...

On August 1, 2024, the U.S. Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an untitled letter to Mirati Therapeutics Inc., a Bristol Myers Squibb Co.

Tracks the change in total value of sales, as well as the total number of lots offered and sold annually in the art market. This chart shows whether Mario Schifano’s total sales are going up, and if ...

The FDA, which issued India’s Laurus Synthesis a Form 483 in January, followed up the action with an "untitled letter" that outlined the Indian drugmaker’s problems with its quality control ...

Alphatec Holdings, Inc. ATEC today commented on the United States Food and Drug Administration's (FDA) untitled letter dated June 23, 2011 that was sent to Parcell Laboratories, LLC regarding ...

“On personalized license-plate configurations, the DMV only allows the letter O, the number zero is not allowed,” Ronald Ongtoaboc, a DMV spokesman, told Honk in an email.

This is a rare and important print from the "Amnesia and Memory" Portfolio of 12 prints, that each demonstrate the stunning range of unique and poignant images by o of the most famous Chinese ...